Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03

Blood

Volumn 97, Issue 1, 2001, Pages 227-234

  Gala, Salvador ^a   Marreiros, Alexandra ^a   Stewart, Graeme J ^a   Williamson, Peter ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035161462     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.227     Document Type: Article

References (49)

1. Jaks and Stats in cytokine signaling
2. Jaks and STATs: Biological implications
3. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
4. Balancing proliferation apoptosis in vivo: The Goldilocks theory of E2F/DP action
5. The retinoblastoma protein and cell cycle control
6. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
7. Cyclin A/cdk2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP 1 by phosphorylation
8. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint
9. DP1 phosphorylation in multimeric complexes: Weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain
10. CDK inhibitors: Positive and negative regulators of G1-phase progression
11. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
12. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27KIP1
13. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor stimulated NIH 3T3 fibroblasts
14. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
15. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
16. E2F1: DP1 induces p53 and overrides survival factors to trigger apoptosis
17. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation
18. The cellular effects of E2F overexpression
19. Established cell lines transformed by E2F-1 overexpression contain wild-type p53
20. Overexpression of p21 waf1/cip1 arrests the growth of chicken embryo fibroblasts that overexpress E2F1
21. Overexpression of E2F1 in astrocytes leads to neoplastic transformation and changes in expression of retinoblastoma family members
22. p53 and E2F-1 cooperate to mediate apoptosis
23. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
24. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity
25. Growth factor modulation of p53-mediated growth arrest versus apoptosis
26. Cytometry of cyclin proteins
27. Protein-PCNA interactions: A DNA-scanning mechanism?
28. G1 phase progression: Cycling on cue
29. Cancer cell cycles
30. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain
31. An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival
32. Genetic evidence for an additional factor required for erythropoietin-induced signal transduction
33. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits
34. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain
35. Constitutive activation of JAK2 confers murine interleukin-3-independent survival and proliteration of BA/F3 cells
36. Jak-STAT pathway is involved in the induction of TNF-beta gene during stimulation by IL-2
37. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation
38. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
39. Accumulation of cyclin B1 requires E2F-1 and cyclin-A-dependent rearrangement of the anaphase-promoting complex
40. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription
41. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis
42. E2F-1 functions in mice to promote apoptosis and suppress proliferation
43. Tumor induction and tissue atrophy in mice lacking E2F-1
44. E2F-1-induced p53-independent apoptosis, in transgenic mice
45. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression
46. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions
47. Increased levels of E2F-1-dependent DNA binding activity after UV- or gamma-irradiation
48. Cell proliferation and apoptosis
49. Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB suppressor protein